These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12185889)

  • 1. Clinical trials of behavioural interventions with heterogeneous teaching subgroup effects.
    Hoover DR
    Stat Med; 2002 May; 21(10):1351-64. PubMed ID: 12185889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings.
    Jewkes R; Nduna M; Levin J; Jama N; Dunkle K; Khuzwayo N; Koss M; Puren A; Wood K; Duvvury N
    Trop Med Int Health; 2006 Jan; 11(1):3-16. PubMed ID: 16398750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials.
    Crepaz N; Lyles CM; Wolitski RJ; Passin WF; Rama SM; Herbst JH; Purcell DW; Malow RM; Stall R;
    AIDS; 2006 Jan; 20(2):143-57. PubMed ID: 16511407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials.
    Mottillo S; Filion KB; Bélisle P; Joseph L; Gervais A; O'Loughlin J; Paradis G; Pihl R; Pilote L; Rinfret S; Tremblay M; Eisenberg MJ
    Eur Heart J; 2009 Mar; 30(6):718-30. PubMed ID: 19109354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statistical analysis of community-based studies -- presentation and comparison of possible solutions with reference to statistical meta-analytic methods].
    Twardella D; Bruckner T; Blettner M
    Gesundheitswesen; 2005 Jan; 67(1):48-55. PubMed ID: 15672306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent human immunodeficiency virus and sexually transmitted disease prevention programmes: are gender-blind approaches justified?
    Ateka GK; Selwyn BJ
    Public Health; 2007 Sep; 121(9):682-9. PubMed ID: 17543358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does stage-based smoking cessation advice in pregnancy result in long-term quitters? 18-month postpartum follow-up of a randomized controlled trial.
    Lawrence T; Aveyard P; Cheng KK; Griffin C; Johnson C; Croghan E
    Addiction; 2005 Jan; 100(1):107-16. PubMed ID: 15598198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling clinical trials in heterogeneous samples.
    Liu W; Zhao W; Shaffer ML; Icitovic N; Chase GA
    Stat Med; 2005 Sep; 24(18):2765-75. PubMed ID: 16007572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for modelling change in cluster randomization trials.
    Klar N; Darlington G
    Stat Med; 2004 Aug; 23(15):2341-57. PubMed ID: 15273952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies.
    Parienti JJ; Kuss O
    Contemp Clin Trials; 2007 May; 28(3):316-23. PubMed ID: 17110172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for testing a prespecified subgroup in clinical trials.
    Song Y; Chi GY
    Stat Med; 2007 Aug; 26(19):3535-49. PubMed ID: 17266164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Transtheoretical Model based interventions on smoking cessation.
    Aveyard P; Massey L; Parsons A; Manaseki S; Griffin C
    Soc Sci Med; 2009 Feb; 68(3):397-403. PubMed ID: 19038483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a behavioral intervention for seropositive youth.
    Lee MB; Leibowitz A; Rotheram-Borus MJ
    AIDS Educ Prev; 2005 Apr; 17(2):105-18. PubMed ID: 15899749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM
    Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.